國際商業結算(00147.HK)附屬就約298.3萬美元連利息債務遭提清盤呈請
國際商業結算(00147.HK)公布,附屬公司國際商業結算接獲呈請人國際商業機器(中國)向香港高等法院提交之清盤呈請,將定於明年1月19日聆訊。
呈請乃針對附屬公司未能償還債務298.3萬美元連同其應計利息,以及申請強制執行中國國際經濟貿易仲裁委員會於2020年4月9日在北京針對該附屬公司以呈請人為受益人,作出的仲裁案件中的仲裁裁決費用及作出裁決書的訟費而遞交。該附屬公司正就呈請尋求法律意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.